JW Pharmaceutical
Seoul
What changed
Phase III trial registered: To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus
10mo agoTrial registeredSep 9, 2025Source filing (opens the source filing in a new tab)
Momentum
Momentum 55 out of 100, unchanged since the last recompute.
Some recent activity, at a steady rate.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Phase III
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R01 · $545k · non-dilutive
Jun 9, 2023WASHINGTON UNIVERSITY · PI CHOI, KYUNGHEE · NCI · award ends May 31, 2028 · Myct1 control of the angioimmune interface
NIH RePORTER · NIH RePORTER 11093939 (opens the source filing in a new tab)
- Trial
PHASE3 registered
Jan 3, 2023Type 2 Diabetes Mellitus · COMPLETED · sponsor: JW Pharmaceutical · To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov · NCT05814393 (opens the source filing in a new tab)
- Grant
R01 · $764k · non-dilutive
May 1, 2021ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHOI, KI SUENG · NIMH · award ends Feb 28, 2027 · Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder
NIH RePORTER · NIH RePORTER 11175481 (opens the source filing in a new tab)
- Grant
R01 · $454k · non-dilutive
Mar 10, 2011TRUSTEES OF INDIANA UNIVERSITY · PI CHOI, KYUNG H · NIAID · award ends Jun 30, 2029 · MECHANISM OF RNA SYNTHESIS BY DENGUE VIRUS NS5
NIH RePORTER · NIH RePORTER 11144982 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources